The Latest Updates
Dr. Mark is the Director of the Outcomes Research Group in the Duke Clinical Research Institute. He has over 25 years of research expertise in cardiovascular disease, clinical trials, observational studies, statistical methodology, comparative effectiveness analyses, and the evaluation of the economic and quality of life consequences of cardiovascular disease and its therapies.
Lectures, Presentations, and Interviews
Quality of Life Results in the TACT Trial
Dan Mark presents the TACT Quality of LIfe substudy results at the Late Breaking Clinical Trials presentation at the American Heart Association Scientific Sessions.